Finally, cpd10 administration suppressed MCL growth in vitro and lymphoma progression in vivo (CCMCL1 cell line transplant into NSG mice) with a confirmed effect on EBF1, IRF4, PAX5, CXCR4, and CD79B mRNA levels. This evidence concerns the gene IRF4 and mantle cell lymphoma.